Lipophilicity in drug discovery
- PMID: 22823020
- DOI: 10.1517/17460441003605098
Lipophilicity in drug discovery
Abstract
Importance of the field: The role of lipophilicity in determining the overall quality of candidate drug molecules is of paramount importance. Recent developments suggest that, as well as determining pre-clinical ADMET (absorption, distribution, metabolism, elimination and toxicology) properties, compounds of optimal lipophilicity might have increased chances of success in development.
Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compound 'quality' with lipophilicity.
What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.
Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3. Some of the implications of this for medicinal chemistry optimisation are discussed.
Similar articles
-
The influence of lipophilicity in drug discovery and design.Expert Opin Drug Discov. 2012 Oct;7(10):863-75. doi: 10.1517/17460441.2012.714363. Epub 2012 Sep 19. Expert Opin Drug Discov. 2012. PMID: 22992175 Review.
-
Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.Expert Opin Drug Metab Toxicol. 2010 Mar;6(3):321-36. doi: 10.1517/17425250903547829. Expert Opin Drug Metab Toxicol. 2010. PMID: 20163321 Review.
-
Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.Chem Res Toxicol. 2011 Sep 19;24(9):1420-56. doi: 10.1021/tx200211v. Epub 2011 Jul 26. Chem Res Toxicol. 2011. PMID: 21790149 Review.
-
Advances in LC platforms for drug discovery.Expert Opin Drug Discov. 2010 May;5(5):475-89. doi: 10.1517/17460441003733874. Epub 2010 Apr 5. Expert Opin Drug Discov. 2010. PMID: 22823131
-
Advances in visual representation of molecular potentials.Expert Opin Drug Discov. 2010 Jun;5(6):513-27. doi: 10.1517/17460441.2010.484837. Epub 2010 Apr 30. Expert Opin Drug Discov. 2010. PMID: 22823164
Cited by
-
Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity.J Med Chem. 2021 Apr 8;64(7):4089-4108. doi: 10.1021/acs.jmedchem.0c02223. Epub 2021 Mar 18. J Med Chem. 2021. PMID: 33733768 Free PMC article.
-
Surface-Mediated Molecular Transport of a Lipophilic Fluorescent Probe in Polydisperse Oil-in-Water Emulsions.Langmuir. 2023 Mar 28;39(12):4207-4215. doi: 10.1021/acs.langmuir.2c02597. Epub 2023 Mar 15. Langmuir. 2023. PMID: 36919825 Free PMC article.
-
How medicinal chemists learned about log P.J Comput Aided Mol Des. 2018 Aug;32(8):809-819. doi: 10.1007/s10822-018-0127-9. Epub 2018 Jul 17. J Comput Aided Mol Des. 2018. PMID: 30019206 Review.
-
Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4.Medchemcomm. 2017 Apr 20;8(6):1246-1254. doi: 10.1039/c7md00078b. eCollection 2017 Jun 1. Medchemcomm. 2017. PMID: 30108835 Free PMC article.
-
Identification of novel potential antibiotics against Staphylococcus using structure-based drug screening targeting dihydrofolate reductase.J Chem Inf Model. 2014 Apr 28;54(4):1242-53. doi: 10.1021/ci400686d. Epub 2014 Apr 2. J Chem Inf Model. 2014. PMID: 24655350 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials